Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 2/3 1

Status

Unknown 3Completed 2

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 92Other 28Other hematologic neoplasm 9Plasma cell 5Lymphoid 5Gastrointestinal 5Sarcoma 4Breast 3Thoracic 2Genitourinary 1Classical hematology 1CNS 1

Conditions

Colorectal Neoplasms 5925Pancreatic Neoplasms 3552Carcinoma, Hepatocellular 3264Stomach Neoplasms 3051Colonic Neoplasms 2326Rectal Neoplasms 2186Esophageal Neoplasms 1797Liver Neoplasms 1246Neoplasms 1179Breast Neoplasms 1062Neoplasm Metastasis 867Carcinoma, Non-Small-Cell Lung 789Lung Neoplasms 743Cholangiocarcinoma 737Gastrointestinal Neoplasms 661Ovarian Neoplasms 628Esophageal Squamous Cell Carcinoma 581Prostatic Neoplasms 483Melanoma 457Biliary Tract Neoplasms 438Head and Neck Neoplasms 376Uterine Cervical Neoplasms 342Carcinoma, Renal Cell 327Gastrointestinal Stromal Tumors 324Adenocarcinoma Of Esophagus 315Sarcoma 303Barrett Esophagus 300Anus Neoplasms 284Gallbladder Neoplasms 281Urinary Bladder Neoplasms 280

Interventions

golotimod 1ankaferd blood stopper 1Toothbrushing 1Sodium Chloride 1Losartan 1Fibroblast Growth Factor 7 1Bicarbonates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Stomatitis × Gastrointestinal × Clear all
NCT05871333 2023-07-19

Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

Ain Shams University

Phase 2 Unknown
80 enrolled
Gastrointestinal

Stomatitis, Colorectal Neoplasms

NCT05438771 2023-06-01

ABS

Uludag University

Phase NA Unknown
66 enrolled
Gastrointestinal

Colonic Neoplasms, Stomatitis, Colorectal Neoplasms

NCT01265810 2017-11-13

COMTT

Impaqtt Foundation

Phase 3 Completed
64 enrolled
GastrointestinalGenitourinarySarcoma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Stomatitis, Gastrointestinal Stromal Tumors

NCT00393822 2014-07-15

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer

Amgen

Phase 2/3 Completed
100 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms, Stomatitis

NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

SciClone Pharmaceuticals

Phase 2 Unknown
160 enrolled
GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡